Wednesday September 20th 2017

Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension

Conclusion: Continuous fingolimod treatment for up to 12 months was associated with maintained or improved efficacy and a manageable safety profile, consistent with that previously seen. Results in a small number of patients suggest lack of benefit in AQP4 antibody-positive patients. Meaningful statistical interpretation was limited by the small sample size in each treatment group, owing to the number of patients who completed the core study.Trial registrationClinicalTrials.gov NCT00670449 (Source: BMC Neurology)

MedWorm Sponsor Message: Find the best Christmas Sales, Boxing Day Sales and January Sales here.

View original post here:

Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension

Leave a Comment

More from category

New man-made antioxidant could help improve success rates of cell-based therapies
New man-made antioxidant could help improve success rates of cell-based therapies

Cell therapies being developed to treat a range of conditions could be improved by a chemical compound that aids their [Read More]

Patient and Provider Organizations Oppose Graham-Cassidy Health Care Proposal
Patient and Provider Organizations Oppose Graham-Cassidy Health Care Proposal

/About-the-Society/News/Patient-and-Provider-Organizations-Oppose-Graham-C [Read More]

Researchers Discover Potential Driver of MS Disease Progression and Test Ways to Block It
Researchers Discover Potential Driver of MS Disease Progression and Test Ways to Block It

/About-the-Society/News/Researchers-Discover-Potential-Driver-of-MS-Diseas [Read More]

Scientists discover markers for progressive multiple sclerosis
Scientists discover markers for progressive multiple sclerosis

Scientists have uncovered two closely related cytokines -- molecules involved in cell communication and movement -- [Read More]

Study uncovers markers for severe form of multiple sclerosis
Study uncovers markers for severe form of multiple sclerosis

Scientists have uncovered two molecules involved in cell communication and movement that may explain why some people [Read More]